Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-10-10
2006-10-10
O'Hara, Eileen B. (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S287200, C536S023500, C536S024310, C530S350000
Reexamination Certificate
active
07118863
ABSTRACT:
The present invention provides a purified polynucleotide encoding a novel receptor, designated NTR3, which belongs to the TNF receptor gene superfamily; to purified NTR3 polypeptide molecules; to antibodies that bind NTR3; to materials comprising such molecules; and to methods of using such molecules.
REFERENCES:
patent: 5312733 (1994-05-01), MacLeod
patent: 5489743 (1996-02-01), Robinson et al.
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5843789 (1998-12-01), Nomura et al.
patent: 5863769 (1999-01-01), Young
patent: 5885800 (1999-03-01), Emery et al.
patent: 6271366 (2001-08-01), Kimura et al.
patent: 6274339 (2001-08-01), Moore et al.
patent: 6599719 (2003-07-01), Yu et al.
patent: 6627199 (2003-09-01), Saris
patent: 6764679 (2004-07-01), Ashkenazi et al.
patent: 2002/0111325 (2002-08-01), Li et al.
patent: 2002/0150534 (2002-10-01), Yu et al.
patent: 2002/0150583 (2002-10-01), Gentz et al.
patent: 2003/0027284 (2003-02-01), Yu et al.
patent: 2003/0082736 (2003-05-01), Smith
patent: 2003/0096355 (2003-05-01), Zhang
patent: 2003/0129189 (2003-07-01), Yu et al.
patent: 2003/0198640 (2003-10-01), Yu et al.
patent: 2004/0013664 (2004-01-01), Gentz et al.
patent: 19809978 (1999-09-01), None
patent: 0 648 783 (1995-04-01), None
patent: 0861850 (1998-09-01), None
patent: WO 98/30694 (1988-07-01), None
patent: 93/19777 (1993-10-01), None
patent: 94/06476 (1994-03-01), None
patent: WO 96/14328 (1996-05-01), None
patent: WO 96/37609 (1996-11-01), None
patent: 98/35986 (1998-07-01), None
patent: WO 98/30694 (1998-07-01), None
patent: 98/43998 (1998-10-01), None
patent: 99/03992 (1999-01-01), None
patent: WO 99/04001 (1999-01-01), None
patent: WO 99/06426 (1999-02-01), None
patent: WO 99/07738 (1999-02-01), None
patent: WO 99/11791 (1999-03-01), None
patent: WO 99/14330 (1999-03-01), None
patent: WO 99/20758 (1999-04-01), None
patent: WO 99/23105 (1999-05-01), None
patent: WO 99/26977 (1999-06-01), None
patent: WO 99/31128 (1999-06-01), None
patent: WO 99/35268 (1999-07-01), None
patent: WO 99/50413 (1999-10-01), None
patent: WO 99/51744 (1999-10-01), None
patent: WO 00/08139 (2000-02-01), None
patent: WO 00/18800 (2000-04-01), None
Degli-Esposti et al., “Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family”, The Rockefeller University Press, vol. 186, No. 7, Oct. 6, 1997, pp. 1165-1170.
Pan et al., “TRUDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling,” FEBS Letters 424, Jan. 12, 1998, pp. 41-45.
Delgli-Esposti, “To die or not to die-the quest of the TRAIL receptors”, Journal of Leukocyte Biology, vol. 65, May 1999, pp. 535-542.
Schneider et al., “Characterization of two receptors for TRAIL”, FEBS Letters 416, Sep. 24, 1997, pp. 329-334.
McFarlane et al., “Identification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL”, The Journal of Biological Chemistry, vol. 272, No. 41, Jul. 28, 1997, pp. 25417-25420.
Meurs et al., “Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase”, Proc. Natl. Acad. Sci. USA, vol. 90, Jan. 1993, pp. 232-236.
Walczak et al., “TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL”, The EMBO Journal, vol. 16, No. 17, 1997, pp. 5386-5397.
“KILLER/DR5 is a DNA damage-inducible p. 53-regulated death receptor gene”, Nature Genetics, vol. 17, Oct. 1997, pp. 141-143.
Degli-Esposti, et al., “The Novel Receptor TRAIL-R4 Induces NF-kb and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain”, Immunity, vol. 7, Dec. 1997, pp. 813-820.
Naismith et al., “Modularity in the TNF-receptor family”, TIBS 23, Feb. 1998, pp. 74-79.
Hofmann, “The modular nature of apoptotic signaling proteins”, CMLS, vol. 55, 1999, pp. 1113-1128.
Marsters, et al., “A novel receptor for ApoL/TRAIL contains a truncated death domain”, Current Biology, vol. 7, No. 12, 1997, pp. 1003-1006.
Pitti, et al., “Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer”, Nature, vol. 396, Dec. 17, 1998, pp. 699-703.
Sheridan et al., “Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors”, Science, vol. 277, Aug. 8, 1997, pp. 818-821.
Simonet et al., “Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density”, Cell, vol. 89, Apr. 18, 1997, pp. 309-319.
Griffith et al., “TRAIL: a molecule with multiple receptors and control mechanisms”, pp. 559-563.
Emery et al., “Osteoprotegerin is a Receptor for the Cytotoxic Ligand TRAIL”, The Journal of Biological Chemistry, vol. 273, No. 23, Jun. 5, 1998, pp. 1463-1467.
Pan et al., “The Receptor for the Cytotoxic Ligand TRAIL”, Science, vol. 276, Apr. 4, 1997, pp. 111-113.
Pan et al., “An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL”, Science, vol. 277, Aug. 8, 1997, pp. 815-818.
Bucay et al., “osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification”, Genes & Development, vol. 12, 1998, pp. 1260-1268.
Wu et al., “Molecular Cloning and Functional Analysis of the Mouse Homologue of the KILLER/DR5 Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor”, Cancer Research, vol. 59, Jun. 15, 1999, pp. 2770-2775.
Griffith, et al., “Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor-related Cytokine, TRAIL”, vol. 189, No. 8, Apr. 19, 1999, pp. 1343-1353.
Griffith, et al., “Functional Analysis of TRAIL Receptors Using Monoclonal Antibodies”, The Journal of Immunology, 1999, pp. 2597-2605.
Bamias et al., “Expression, Localization, and Functional Activity of TL1A, a Novel Th1-Polarizing cytokine in Inflammatory Bowel Disease,” Journal of Immunology, 171:4868-4874, (2003).
Chew et al., “A Novel Secreted Splice Variant of Vascular Endothelial Cell Growth Inhibitor,” FASEB Journal, 16:742-744 (May 2002).
Chen et al., “Quantification and Detection of DcR3, a Decoy Receptor in TNFR Family,” Journal of Immunological Methods 285:63-70, (2004).
Connolly et al., “In Vivo Inhibition of Fas Ligand-Mediated Killing by TR6, a Fas Ligand Decoy Receptor,” J. Pharmacology and Experimental Therapeutics, 298(1):25-33, (2001).
Gill et al., “Differential Expression of LIGHT and its Receptors in Human Placental Villi and Amniochorion Membranes,” American Journal of Pathology, 161(6):2011-2017, (Dec. 2002).
Hsu et al., “Enhanced Adhesion of Monocytes Via Reverse Signaling Triggered by Decoy Receptor 3,” Experimental Cell Research, 292:241-251, (2004).
Kim et al., “Selective Induction of Tumor Necrosis Receptor factor 6/Decoy Receptor 3 Release by Bacterial Antigens in Human Monocytes and Myeloid Dendritic Cells,” Infection and Immunity, 72(1):89-93, (Jan. 2004).
Migone, et al., TL1A is a TNF-Like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell Costimulator,: Immunity, 16:479-492, (Mar. 2002).
Perry et al., “Characterization of Proximal Colonic Lymphoid Tissue in the Mouse,” The Anatomical Record, 220:305-312 (1988).
Pitti et al., “Genomic Amplification of a Decoy Receptor for Fas Ligand in Lung and Colon Cancer,” Nature, 396:699-703, (Dec. 17, 1998).
Shi et al., “Death Decoy Receptor TR6/DcR3 Inhibits T Cell Chemotaxis In Vitro and In Vivo,” Journal of Immunology, 171:3407-3414, (2003).
Shi et al., “Mouse T Cells Receive Costimulatory Signals from LIGHT, a TNF Family Member,” Immunobiology, 100(9):3279-3286, (Nov. 1, 2002).
Tan et al., “Characterization of a Novel TNF-Like Ligand and Recently Described TNF Ligand and TNF Receptor Superfamily Genes and Their Constitutive and Inducible Expression in Hematopoietic and Non-hematopoietic Cells,” Gene, 204:35-46
Amgen Inc.
O'Hara Eileen B.
LandOfFree
Methods for detecting NTR3 nucleic acids by hybridization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting NTR3 nucleic acids by hybridization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting NTR3 nucleic acids by hybridization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3638726